Nov 15 (Reuters) - Eyenovia Inc EYEN.O:
EYENOVIA PROVIDES UPDATE ON PHASE 3 CHAPERONE STUDY
EYENOVIA INC - COMPANY TO DISCONTINUE STUDY, REVIEW FULL DATA SET, AND EVALUATE NEXT STEPS FOR PROGRAM
EYENOVIA INC: COMPANY TO DISCONTINUE STUDY
EYENOVIA INC: COMPANY TO DISCONTINUE STUDY, REVIEW FULL DATA SET, AND EVALUATE NEXT STEPS FOR PROGRAM
EYENOVIA INC: CONSIDERING STEPS TO MAXIMIZE VALUE TO ALL STAKEHOLDERS, TO REDUCE EXPENSES AND TO EVALUATE ITS STRATEGIC OPTIONS
EYENOVIA: REVIEW OF STUDY DATA BY INDEPENDENT DATA REVIEW COMMITTEE FOUND CHAPERONE IS NOT MEETING PRIMARY 3-YEAR EFFICACY ENDPOINT
Source text: nGNXD2mLj
Further company coverage: EYEN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.